<scp>GLP</scp>‐1 agonists and <scp>SGLT</scp>‐2 inhibitors in adults with sickle cell disease

Authors:

Published: 0000-00-00

DOI: HTTPS://DOI.ORG/10.1002/ajh.27348

Keywords:

Abstract:

Source: